Indian healthcare startup Qure.ai has secured US$65 million in a Series D funding round, led by Lightspeed Venture Partners and 360 ONE Asset Management.

Other key investors included Merck & Co.’s Global Health Innovation Fund, Kae Capital, and existing backers Novo Holdings, Health Quad, and TeamFund.

Qure.AI plans to use the funds to expand its operations in the United States and other markets. The company aims to improve its generative AI models for better disease detection and explore potential acquisitions.

Founded in 2016 and headquartered in Mumbai, Qure.AI detects and manages serious health conditions. The company has over 3,000 diagnostic centers in more than 90 countries.